Plant · Scientific monograph
Actaea racemosa
Black cohosh
For educational and scientific research only. Not medical advice. Independently verify claims against the cited primary sources. Consult a qualified healthcare professional before using any plant or fungal preparation.
Research areas: Menopause research, Traditional North American use
Research overview
Historical use
Black cohosh root/rhizome has documented North American traditional use; modern products vary and require authenticated species and preparation [5].
Modern research context
A systematic review found inconsistent results across randomized trials for menopausal symptoms [1]. A 12-month trial found no significant vasomotor-symptom benefit over placebo [2]; a smaller 8-week trial of one root extract cannot settle efficacy for all products [3].
Adverse effects
Liver-injury reports have been described, but causality is uncertain and adulteration/misidentification complicates attribution. A review is not proof that the species caused each case [4,5].
Contraindications
Product identity and extraction method matter; use only authenticated A. racemosa evidence. The available trials do not establish long-term efficacy or safety for all products [1-5].
Clinical and phytochemical data
Used part
Root and rhizome extracts; trial results apply only to the specific extract tested [2,3].
Primary active compounds
Triterpene glycosides and phenolic acids are described in phytochemical reviews; commercial-product composition varies [5].
Mechanism of action
Clinical trials do not establish a validated human mechanism for symptom changes [1-3].
Pharmacokinetics
Absorption
Human PK data remain insufficient across products; no general exposure profile is established [1,4].
Distribution
Not characterized consistently for clinical products [1,4].
Metabolism
Not characterized adequately for a general product-specific profile [1,4].
Excretion
Not characterized adequately for a general product-specific profile [1,4].
Safety and interactions
Drug interactions
No interaction profile can be generalized across products from the cited trials; clinically significant interactions remain insufficiently characterized [1,4].
Toxicity
Liver injury has been reported with products labelled black cohosh; causality and product identity are uncertain [4,5].
Special precautions
Pregnancy
Pregnancy safety is not established; use is not supported by the cited menopause trials.
Lactation
Lactation safety is not established.
Hepatic impairment
Given reported liver-injury cases and limited causal certainty, hepatic disease warrants medical review before use; no dose adjustment evidence is established [4].
Renal impairment
Renal impairment data are insufficient.
Sources and references
- [1] Francesca Borrelli, Edzard Ernst. Black cohosh (Cimicifuga racemosa) for menopausal symptoms: a systematic review of its efficacy. Pharmacological Research. 2008;58(1):8–14. PMID: 18585461. DOI: 10.1016/j.phrs.2008.05.008.
- [2] S. E. Geller et al. Safety and efficacy of black cohosh and red clover for the management of vasomotor symptoms: a randomized controlled trial. Menopause. 2009;16(6):1156–1166. PMID: 19609225. DOI: 10.1097/gme.0b013e3181ace49b.
- [3] S. Mohammad-Alizadeh-Charandabi et al. Efficacy of black cohosh (Cimicifuga racemosa L.) in treating early symptoms of menopause: a randomized clinical trial. Chinese Medicine. 2013;8:20. PMID: 24499633. DOI: 10.1186/1749-8546-8-20.
- [4] Yuan Le et al. Review of black cohosh-induced toxicity and adverse clinical effects. Journal of Environmental Science and Health, Part C: Toxicology and Carcinogenesis. 2025;43(3):243–268. PMID: 40503925. DOI: 10.1080/26896583.2025.2513795.
- [5] Sofia Salari et al. Ethnobotany, Phytochemistry, Traditional and Modern Uses of Actaea racemosa L. (Black cohosh): A Review. Advances in Experimental Medicine and Biology. 2021;1308:403–449. PMID: 33861455. DOI: 10.1007/978-3-030-64872-5_24.